Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Israel Biotech Fund

Investor type Micro VC
Founders David Sidransky Yuval Cabilly


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 11
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Lead investments 5
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 3
Key employees 3

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Therapeutics
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Israel Biotech Fund:
Typical Co-investors
Israel Biotech Fund is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Israel Biotech Fund:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Anchor Group Geneva, Geneve, Switzerland
BKCM New York, New York, United States
Convoy Global Holdings China, Hong Kong, Hong Kong Island
Cowen Healthcare Investments New York, New York, United States
Drexel Hamilton, LLC -
Nesnah Ventures LLC La Crosse, United States, Wisconsin
Poplar Ventures Kentucky, Louisville, United States
Prelude Trust England, London, United Kingdom
Rockefeller Foundation New York, New York, United States
Startupbootcamp FinTech Dubai Dubai, United Arab Emirates

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Medical Device
$30M22 Sep 2022 Yavne, HaMerkaz, Israel

Vensica Medical

Health Care
Medical Device
$16M01 Nov 2021 Misgav, HaZafon, Israel

Life Science
$28M13 May 2021 Jerusalem, Jerusalem District, Israel


Health Care
$27M02 Dec 2020 Israel, North District


Health Care
$19M11 Mar 2020 Israel, North District

Ayala Pharmaceuticals

$30M28 May 2019 Israel, Center District

Biond Biologics

Health Care
$17M08 Jan 2019 Israel, North District

Ayala Pharmaceuticals

$17M10 Apr 2018 Israel, Center District

Gamida Cell

Health Care
Medical Device
$40M19 Jun 2017 Israel, Jerusalem District
Vensica Therapeutics Closes $16 Million Investment Round

– Vensica closed an investment round of $16m.
– The round was led by Israel Biotech Fund (“IBF”), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical companies.
– Other investors in the round include Laborie, a global urology device company, Lew Pell, an experienced medical device investor, Agriline, a trust of which Vincent Tchenguiz is a discretionary beneficiary, and The Trendlines Group, an investor in innovation-based medical and agricultural technologies.
– Funds raised will support the company’s phase II multicenter clinical trials in Europe and the USA.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Israel Biotech Fund?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: